Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06917586 · ClinicalTrials.gov registry record
Mosaic Mitral Valve: Long-Term Outcomes in Patients Under 65
A clinical trial of Valve Disease, Heart and Valve Replacement, sponsored by Michael Moront.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT06917586: Recruiting study of Valve Disease, Heart and Valve Replacement, sponsored by Michael Moront.
NCT06917586 is a study of Valve Disease, Heart and Valve Replacement that is actively recruiting participants, run by Michael Moront. The registered enrollment target is 300 participants, below the 671-participant average among 5 other Valve Disease, Heart trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06917586, a study of Valve Disease, Heart and Valve Replacement, is actively recruiting participants, sponsored by Michael Moront.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The safety and efficacy of the Mosaic bioprosthetic heart valves for cardiac valve replacement in the aortic position has been well documented throughout the literature. However, few studies assessing structural valve deficiency, patient outcomes and overall product performance in patients under the age of 65 exists for the Mosaic mitral valve bioprosthetic. This study aims to assess valve efficacy, stability, and post operative outcomes in patients who have received the Mosaic mitral valve prothesis at ProMedica Toledo Hospital and were under the age of 65.
Primary Outcome
Mortality in patients who were under the age of 65 when receiving the mosaic mitral valve bioprosthetic at ProMedica hospital. Patient records will be reviewed to determine mortality rate of patients who were under 65 years of age when receiving the mosaic mitral valve bioprosthetic.
Conditions Studied
Study Locations (1)
Ohio
- ProMedica Toledo Hospital - Toledo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2025-01-01 |
| Est. Completion | 2027-07-01 |
What NCT06917586 shows while recruiting
NCT06917586 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 671-participant average among 5 other Valve Disease, Heart trials with a reported enrollment target (55% lower).
The record links to 4 conditions, with Valve Disease, Heart appearing as the primary indexed condition, and to 0 interventions.
NCT06917586 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06917586 about?
NCT06917586 is a clinical study titled "Mosaic Mitral Valve: Long-Term Outcomes in Patients Under 65". The safety and efficacy of the Mosaic bioprosthetic heart valves for cardiac valve replacement in the aortic position has been well documented throughout the literature. However, few studies assessing structural valve deficiency, patient outcomes and overall product performance in patients under the...
What is the current status of trial NCT06917586?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2025-01-01. Estimated completion is 2027-07-01.
What conditions does trial NCT06917586 study?
This clinical trial studies the following conditions: Valve Disease, Heart, Valve Replacement, Valve Regurgitation, Mitral, Valve Heart Stenosis.
Who is sponsoring clinical trial NCT06917586?
This trial is sponsored by Michael Moront, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06917586 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Valve Disease, Heart
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
-
Medtronic Cardiac Surgery PMCF Registry
RECRUITING
-
Allogeneic Valve Transplantation
RECRUITING · NA
-
Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization
RECRUITING
-
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI